6 reports

Oral Contraceptive and Cancer Risks.

  • Breast Cancer
  • East Asia
  • North America
  • Pfizer Inc.
  • Roche Group

Combination hormone products, such as the estrogen + progestin contraceptive pill, have also been associated with an increased risk of breast cancer (NCI, 2016).

  • Breast Cancer
  • North America
  • United States
  • Novartis AG
  • Pfizer Inc.

Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Wactawski-Wende J, et al. (2011) Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer.

  • Breast Cancer
  • North America
  • AstraZeneca PLC
  • Eisai Co., Ltd.
  • TESARO, Inc.
  • 4.2 KEY MARKET DRIVERS

This can majorly be attributed to changing lifestyles, increasing use of oral contraceptives, and the growing number of women undergoing cosmetic surgeries such as breast enhancement.

  • Breast Cancer
  • North America
  • United States
  • Forecast
  • Cianna Medical, Inc.

ASTRAZENECA REGISTERED A PHASE I SINGLE-BLIND, PLACEBO-CONTROLLED, ##-PERIOD, FIXED SEQUENCE STUDY TO EVALUATE THE SAFETY, EFFICACY AND TOLERABILITY OF COADMINISTRATION OF FOSTAMATINIB ## MG TWICE DAILY ON THE PHARMACOKINETICS OF AN ORAL CONTRACEPTIVE IN HEALTHY FEMALE SUBJECTS.

  • Breast Cancer
  • Ovarian Cancer
  • Therapy
  • North America
  • Merck & Co., Inc.

This can majorly be attributed to changing lifestyles, increasing use of oral contraceptives, and growing number of women undergoing cosmetic surgeries like breast enhancement.

  • Breast Cancer
  • Mammography Equipment
  • North America
  • Market Size
  • Hologic, Inc.